Company news

TherapeuticsMD, Inc. news in 2020

TherapeuticsMD, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Comedian Whitney Cummings Partners with TherapeuticsMD to Launch “Just Say Vagina”

December 14, 2020

TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference

November 12, 2020

TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock

November 9, 2020

TherapeuticsMD® Announces Third Quarter 2020 Financial Results

November 8, 2020

TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020

October 28, 2020

TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health

October 8, 2020

TherapeuticsMD Provides Update on Third Quarter Progress

September 24, 2020

Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®

September 20, 2020

TherapeuticsMD Announces Participation at Two Upcoming Virtual Investor Conferences

September 9, 2020

TherapeuticsMD Announces Patent Updates for ANNOVERA®

September 8, 2020

Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®

August 24, 2020

TherapeuticsMD® Announces Second Quarter 2020 Financial Results

August 5, 2020

TherapeuticsMD to Report Second Quarter 2020 Results on August 6, 2020

July 28, 2020

TherapeuticsMD and Nurx Expand Access to ANNOVERA®

July 14, 2020

TherapeuticsMD Announces Appointment of James C. D’Arecca as Chief Financial Officer and Retirement of Daniel A. Cartwright as Chief Financial Officer

May 31, 2020

TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference

May 7, 2020

TherapeuticsMD Announces First Quarter 2020 Financial Results

May 5, 2020

TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA®

April 28, 2020

TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020

April 27, 2020

TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director

April 21, 2020

TherapeuticsMD Provides COVID-19-Related Business Update

March 25, 2020

TherapeuticsMD Strengthens Board with Appointment of Industry Leaders

March 23, 2020

TherapeuticsMD Provides Business Update on COVID-19 Pandemic

March 15, 2020

TherapeuticsMD Announces Participation at the Cowen 40th Annual Healthcare Conference

February 26, 2020

TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results

February 19, 2020

TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector

February 12, 2020

TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020

February 9, 2020

TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA®

February 2, 2020

TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products

January 6, 2020

TherapeuticsMD, an Innovative Women’s Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Women’s Health Products

January 6, 2020

TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference

January 5, 2020

Decks in 2020